MAGNETIC RESONANCE SPECTROSCOPY AND CANCER TREATMENT

NIH GUIDE, Volume 21, No. 23, June 26, 1992



PA NUMBER:  PA-92-86



P.T. 34



Keywords:

  Cancer/Carcinogenesis 

  Medical/Diagnostic Imaging 



National Cancer Institute



The following corrections are made to this program announcement that

was published in the NIH Guide for Grants and Contracts on June 12,

1992, Vol. 21, No. 22.



The NIH Guide reference in the heading contained the incorrect number

and date; the correct information is NIH GUIDE, Vol. 21, No. 22, June

12 1992.



The first sentence of the third paragraph under Background Information,

RESEARCH OBJECTIVES, should read as follows:  "The goal of this

initiative is to conduct well-focused, prospective clinical studies

using currently available, routinely applicable, methodology to begin

comprehensive testing of the potential for MRS to predict and/or detect

therapeutic response in patients with tumors."



The first sentence of the second paragraph under Research Goals and

Scope, RESEARCH OBJECTIVES, should read as follows:  "This announcement

seeks to encourage the following research topics in conventional MRI-

guided MRS in preclinical and clinical cancer research."



The last paragraph under METHOD OF APPLYING is replaced with the

following paragraph:



"If the application submitted in response to this RFA is substantially

similar to a grant application already submitted to the NIH for review,

but has not yet been reviewed, the applicant will be asked to withdraw

either the pending application or the new one.  Simultaneous submission

of identical applications will not be allowed, nor will essentially

identical applications be reviewed by different review committees.

Therefore, an application cannot be submitted in response to this RFA

that is essentially identical to one that has already been reviewed.

This does not preclude the submission of substantial revisions of

applications already reviewed, but such applications must include an

introduction addressing the previous critique.



INQUIRIES



Questions and inquiries concerning this program announcement are to be

directed to:



Faina Shtern, M.D.

Chief, Diagnostic Imaging Research Branch

Radiation Research Program

National Cancer Institute

Executive Plaza North, Suite 800

Bethesda, MD  20892

Telephone:  (301) 496-9531



.

Return to 1992 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.